When Lightning Strikes: The Mental Health Implications for Individuals Newly Diagnosed With Rheumatoid Arthritis
No Thumbnail Available
Authors
Bennett, Natalie
Issue Date
2024-05-02
Type
Capstone
Language
en
Keywords
fatigue , rheumatoid arthritis , mental disorder , major depressive disorder , generalized anxiety disorder , GAD , anxiety , MDD , depression , mental illness
Alternative Title
Abstract
Rheumatoid arthritis is a chronic, incurable, autoimmune disease that has debilitating side effects such as pain, fatigue, inflammation, joint damage, and decreased mobility. Over time, it can lead to disability, rendering some people unable to work and perform daily tasks. RA impacts all areas of people’s lives: physical, mental, and social. Mental health disorders, specifically depression and anxiety, are common in individuals newly diagnosed with RA; however, there is a gap in the diagnosis and treatment of psychological disorders in early RA. A biopsychosocial approach to the treatment of RA is recommended; integrating medical and psychological interventions has been demonstrated to have a positive effect on health outcomes. There is a bidirectional relationship between RA and depression, and it is recommended that RA be treated early using a treat-to-target response using medications such as NSAIDs, biologics (DMARDS) and Jak inhibitors. Psychiatric medications are a treatment option for comorbid mental health disorders. Psychological interventions such as CBT, mindfulness practices, patient education, yoga, and exercise have been shown to be beneficial in treating RA in conjunction with pharmacology. Many individuals are reluctant to disclose mental health concerns to their physician due to barriers including stigma, fears, and beliefs about RA and medication side effects, resulting in a high level of physician-patient discordance. Mental health professionals are an important part of the multidisciplinary team who can support individuals newly diagnosed with RA with comorbid depression and/or anxiety.